Screener
Travere Therapeutics, Inc. TVTX Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
FAQ
- What is Travere Therapeutics, Inc.'s gross profit?
- Travere Therapeutics, Inc. (TVTX) reported gross profit of $125.25M in Q1 2026.
- How has Travere Therapeutics, Inc.'s gross profit changed year-over-year?
- Travere Therapeutics, Inc.'s gross profit increased by 62.5% year-over-year, from $77.05M to $125.25M.
- What is the long-term trend for Travere Therapeutics, Inc.'s gross profit?
- Over 3 years (2022 to 2025), Travere Therapeutics, Inc.'s gross profit has grown at a 66.9% compound annual growth rate (CAGR), from $103.29M to $480.39M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Travere Therapeutics, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude